Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Imaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue.

Diabetologia | 2019

The molecular response and function of pancreatic islet cells during metabolic stress is a complex process. The anatomical location and small size of pancreatic islets coupled with current methodological limitations have prevented the achievement of a complete, coherent picture of the role that lipids and proteins play in cellular processes under normal conditions and in diseased states. Herein, we describe the development of untargeted tissue imaging mass spectrometry (IMS) technologies for the study of in situ protein and, more specifically, lipid distributions in murine and human pancreases.

Pubmed ID: 30955045 RIS Download

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK104218
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK104211
  • Agency: NIDDK NIH HHS, United States
    Id: U54 DK120058
  • Agency: NIGMS NIH HHS, United States
    Id: P41 GM103391
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK108120
  • Agency: NIDDK NIH HHS, United States
    Id: F32 DK105841
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK072473
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK112232
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK089572
  • Agency: NCI NIH HHS, United States
    Id: P30 CA068485
  • Agency: NIDDK NIH HHS, United States
    Id: R24 DK106755
  • Agency: NIDDK NIH HHS, United States
    Id: U24 DK059637
  • Agency: NIH HHS, United States
    Id: S10 OD021630
  • Agency: NIDDK NIH HHS, United States
    Id: U2C DK059637
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK094199
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK020593
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK104218
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK097829

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Human Islet Research Network (HIRN) (data or information resource)

RRID:SCR_014393

Network helps to organize and support collaborative research related to loss of functional beta cell mass in Type 1 Diabetes (T1D). Project consists of four independent research initiatives: Consortium on Beta Cell Death and Survival (CBDS), Consortium on Human Islet Biomimetics (CHIB), Consortium on Modeling Autoimmune Interactions (CMAI), Consortium on Targeting and Regeneration (CTAR), and Human Pancreas Analysis Program (HPAP).

View all literature mentions